Biotech Strategy Blog

Commentary on Science, Innovation & New Products with a focus on Oncology, Hematology & Cancer Immunotherapy

  • Conferences
    • AACR19
    • AACR18
    • AACR17
    • AACR16
    • AACR15
    • AACR14
    • AACR IO
    • AAI ASGCT
    • ASCO GI
    • ASCO GU
    • ASCO-SITC
    • ASCO19
    • ASCO18
    • ASCO17
    • ASCO16
    • ASCO15
    • ASCO14
    • ASH19
    • ASH18
    • ASH17
    • ASH16
    • ASH15
    • AUA
    • BMT
    • CIML40
    • CIMT
    • EACR
    • EAU
    • ECCO
    • ESMO19
    • ESMO18
    • ESMO17
    • ESMO16
    • ESMO14
    • JPM20
    • SABCS
    • SITC 2019
    • SITC 2018
    • SITC 2017
    • SITC 2016
    • SITC 2015
    • SITC 2014
    • Targets19
  • Targets
    • Bispecifics
    • Cytokines
    • MYC
    • Neoantigens
    • RAS
    • STING
  • About
  • Contact
  • Pricing
  • Podcast
  • Premium Content
  • Immuno-Oncology
  • Cell Therapy
  • Interviews
  • Login

  • A look at Mirati in the context of the broader KRAS niche

    Read more

  • A hidden gem in the KRAS niche

    Read more

  • Competition rapidly heats up in the KRAS space!

    Read more

  • Update on the KRAS Runners and Riders

    Read more

  • What do we learn from a first look at Mirati’s KRAS G12C inhibitor MRTX849?

    Read more

  • A novel approach to targeting BRAF and KRAS mutant cancers

    Read more

  • Update on Amgen’s KRAS inhibitor in solid tumours

    Read more
E

A look at Mirati in the context of the broader KRAS niche

An interview with Mirati's Chuck Baum and Jamie Christensen exploring the evolving opportunities and challenges in the KRAS G12C niche

View post
E

Overcoming challenges associated with cell therapy approaches

Insights from Transplantation & Cellular Therapy (TCT) meeting on the next generation of CAR T cells

View post
E

A hidden gem in the KRAS niche

Attention on small molecule inhibitors – after being in the…

View post

Terms of Use & Privacy Policy
Copyright © 2010-20 Biotech Strategy Blog

Free Email Updates
Subscribe to new post alerts, offers, and additional content!
We respect your privacy and do not sell emails. Unsubscribe at any time.
error: Content is protected !!